1. ScholarBank@NUS

Jianbiao Zhou

rp06470

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Jianbiao Zhou
Variants
Zhou J.
Zhou, J.
Zhou, J.B.
Zhou J
Zhou Jianbiao
Zhou, Jianbiao
 
Main Affiliation
 
Faculty
 
Email
csizjb@nus.edu.sg
 

Publications

Refined By:
Department:  CANCER SCIENCE INSTITUTE OF SINGAPORE
Date Issued:  [2010 TO 2019]

Results 1-20 of 34 (Search time: 0.008 seconds).

Issue DateTitleAuthor(s)
12018A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphataseZhou, J ; Toh, S.H.-M; Chan, Z.-L; Quah, J.Y; Chooi, J.-Y ; Tan, T.Z ; Chong, P.S.Y ; Zeng, Q ; Chng, W.-J 
22015Aberrant nuclear factor-kappa B activity in acute myeloid Leukemia: From molecular pathogenesis to therapeutic targetZhou J. ; Ching Y.Q. ; Chng W.-J. 
31-Mar-2011Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profilingNg, Siok-Bian ; Selvarajan, Viknesvaran; Huang, Gaofeng; Zhou, Jianbiao ; Feldman, Andrew L; Law, Mark; Kwong, Yok-Lam; Shimizu, Norio; Kagami, Yoshitoyo; Aozasa, Katsuyuki; Salto-Tellez, Manuel; Chng, Wee-Joo 
414-Jul-2011Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-B: Implication in breast cancer metastasisBist, P.; Leow, S.C.; Phua, Q.H.; Shu, S.; Zhuang, Q.; Loh, W.T.; Nguyen, T.H.; Zhou, J.B. ; Hooi, S.C.; Lim, L.H.K.
511-Jul-2018BET Bromodomain inhibition promotes De-repression of TXNIP and activation of ASK1-MAPK pathway in acute myeloid leukemiaZhou Y.; Zhou J. ; Lu X.; Tan T.-Z. ; Chng W.-J. 
62011Determinants of sensitivity to DZNep induced Apoptosis in multiple myeloma cellsXie, Z. ; Bi, C.; Cheong, L.L.; Liu, S.C.; Huang, G. ; Zhou, J. ; Yu, Q.; Chen, C.-S.; Chng, W.J.
7Feb-2012Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in miceGuo, K.; Tang, J.P.; Jie, L.; Al-Aidaroos, A.Q.O.; Hong, C.W.; Tan, C.P.B.; Park, J.E.; Varghese, L.; Feng, Z.; Zhou, J. ; Chng, W.J.; Zeng, Q. 
82015Functional characterization of D9, a novel deazaneplanocin a (DZNep) analog, in targeting acute myeloid leukemia (AML)Jiang, Xia; Lim, Cheryl Zi Hui; Li, Zhimei; Lee, Puayleng; Yatim, Siti Maryam J. M.; Guan, Peiyong; Li, Juntao; Zhou, Jianbiao ; Pan, Jingxuan; Chng, Wee Joo ; Chai, Li Lin Christina ; Yu, Qiang 
92015Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myelomaBi, C; Chung, T.-H ; Huang, G ; Zhou, J ; Yan, J ; Ahmann, G.J; Fonseca, R; Chng, W.J 
1015-Sep-2019IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple MyelomaChong, Phyllis SY ; Zhou, Jianbiao ; Lim, Julia SL ; Hee, Yan Ting; Chooi, Jing-Yuan ; Chung, Tae-Hoon ; Tan, Zea Tuan ; Zeng, Qi ; Waller, Daniel D; Sebag, Michael; Chng, Wee-Joo 
112017Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemiaZhou, J ; Bi, C; Ching, Y.Q ; Chooi, J.-Y ; Lu, X; Quah, J.Y ; Toh, S.H.-M ; Chan, Z.-L; Tan, T.Z ; Chong, P.S ; Chng, W.-J 
122010ITIH3 Is a potential biomarker for early detection of gastric cancerChong, P.K. ; Lee, H.; Zhou, J. ; Liu, S.-C.; Loh, M.C.S. ; Wang, T.T. ; Lim, Y.P. ; Chan, S.P.; Smoot, D.T.; Ashktorab, H.; So, J.B.Y. ; Lim, K.H.; Yeoh, K.G. 
13May-2013LIN28/LIN28B: An emerging oncogenic driver in cancer stem cellsZhou, J. ; Ng, S.-B.; Chng, W.-J.
141-Mar-2017LIN28B Activation by PRL-3 Promotes Leukemogenesis and a Stem Cell-like Transcriptional Program in AMLZhou, Jianbiao ; Chan, Zit-Liang; Bi, Chonglei; Lu, Xiao; Chong, Phyllis SY ; Chooi, Jing-Yuan ; Cheong, Lip-Lee; Liu, Shaw-Cheng; Ching, Ying Qing ; Zhou, Yafeng; Osato, Motomi; Tan, Tuan Zea ; Ng, Chin Hin ; Ng, Siok-Bian ; Wang, Shi ; Zeng, Qi ; Chng, Wee-Joo 
1526-Apr-2018NF-kappa B promotes the stem-like properties of leukemia cells by activation of LIN28BZhou, Jianbiao ; Chooi, Jing-Yuan ; Ching, Ying Qing ; Quah, Jessie Yiying ; Toh, Sabrina Hui-Min ; Ng, Yvonne ; Tan, Tuan Zea ; Chng, Wee-Joo 
1628-Feb-2019Non-canonical activation of beta-catenin by PRL-3 phosphatase in acute myeloid leukemiaChong, Phyllis SY ; Zhou, Jianbiao ; Chooi, Jing-Yuan ; Chan, Zit-Liang; Toh, Sabrina Hui Min ; Tan, Tuan Zea ; Wee, Sheena; Gunaratne, Jayantha ; Zeng, Qi ; Chng, Wee-Joo 
1724-Sep-2019Novel mechanism of drug resistance to proteasome inhibitors in multiple myeloma.Zhou, Jianbiao ; Chng, Wee-Joo 
18Sep-2013Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemiaPark, J.E.; Yuen, H.F.; Zhou, J.B. ; Al-aidaroos, A.Q.O.; Guo, K.; Valk, P.J.; Zhang, S.D.; Chng, W.J.; Hong, C.W.; Mills, K.; Zeng, Q. 
192015P53 mutations in colorectal cancer- Molecular pathogenesis and pharmacological reactivationLi X.-L; Zhou J ; Chen Z.-R; Chng W.J 
20Nov-2011Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemiaHart, S.; Goh, K.C.; Novotny-Diermayr, V.; Tan, Y.C.; Madan, B.; Amalini, C.; Ong, L.C.; Kheng, B.; Cheong, A.; Zhou, J. ; Chng, W.J.; Wood, J.M.